{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Concentration": ".*",
      "Species": ".*",
      "TimePoint": ".*"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Farah Humayun",
      "contact": "farah.humayun@scai-extern.fraunhofer.de",
      "description": "Heme BEL model is a disease model based on Biological Expression Language (BEL) containing the core mechanisms of heme as modulator in Hemolytic diseases such as sickle-cell anemia, beta-thalassemia, malaria and autoimmune hemolytic anemia.",
      "licenses": "MIT License",
      "name": "heme 28314763.bel",
      "version": "1.0.2"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "HM": ".*",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CTO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns",
      "DO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HBP": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/export/hbp-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/01c9daa61012b37dd0a1bc962521ba51a15b38f1/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "MIRBASE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns",
      "SCOMP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns",
      "SFAM": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"
    },
    "path": "heme_28314763.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Some of the adverse effects caused by cell-free hemoglobin are a result of depletion of nitric oxide (NO), which may lead to vasoconstriction, inflammation, and platelet activation (10, 24).",
      "key": "2743b0e26bcd30ae7aa66b63d7edb594",
      "line": 93,
      "relation": "decreases",
      "source": 15,
      "target": 0
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Compared to wild-type (WT) mice, mice with 117 endothelial dysfunction have an increased vasoconstrictor response to infusion of 118 cell-free hemoglobin (25).",
      "key": "a8faa25ecaa59f14d0e55025131cc8cc",
      "line": 131,
      "relation": "increases",
      "source": 15,
      "target": 22
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Intravenous infusion of cell-free hemoglobin induces hypertension in mice 205 (24).",
      "key": "65229a1c8b2e918ac1135c923d01058c",
      "line": 136,
      "relation": "increases",
      "source": 15,
      "target": 27
    },
    {
      "key": "ec0199677dab53130e262c076fd59010",
      "relation": "partOf",
      "source": 15,
      "target": 12
    },
    {
      "key": "64aff40eebcfea4f5fbe49183a48498c",
      "relation": "partOf",
      "source": 15,
      "target": 13
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "These data suggest that co-administration of human haptoglobin or hemopexin does 276 not attenuate the conversion of NO to nitrate that is mediated by cell-free murine 277 hemoglobin.",
      "key": "070c9f9bdde567647c1a017302acd965",
      "line": 187,
      "relation": "increases",
      "source": 15,
      "target": 29
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Previous studies showed that db/db mice have enhanced 312 susceptibility to hemoglobin-induced vasoconstriction (25).",
      "key": "fd2cfa2ca90a95914968647c5299cc0b",
      "line": 193,
      "relation": "increases",
      "source": 15,
      "target": 8
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "SBP 315 increased 27±2 mmHg during the 40 minutes following infusion of hemoglobin in 316 db/db mice (Figure 4A).",
      "key": "f1230e7a3bbe1a00a8b62d6d46c3f3bd",
      "line": 200,
      "relation": "increases",
      "source": 15,
      "target": 9
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "When mice 347 are infused with extracellular hemoglobin that has been extensively crosslinked and 348 only contains a small fraction of monomeric hemoglobin (as in the HBOCs, 349 PolyHeme), scavenging of NO is markedly reduced (25).",
      "key": "54def7c6d317c342edc07870614165d6",
      "line": 220,
      "relation": "decreases",
      "source": 15,
      "target": 3
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Inhibition of extravasation of cross-linked extracellular 352 hemoglobin has been postulated as a possible mechanism of decreased NO353 scavenging in the muscular layer of arteries by high-molecular weight HBOCs.",
      "key": "2e150a01a869f8f0738c596c49eb1f3e",
      "line": 227,
      "relation": "decreases",
      "source": 15,
      "target": 3
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "The extensive crosslinkage of cell-free hemoglobin in a high-molecular weight HBOC retains cell-free hemoglobin dimers in the intravascular compartment, thereby preventing extravasation 112 of cell-free hemoglobin into the muscular layer of the arteries where local NO consumption can trigger vasoconstriction (25).",
      "key": "c9a0d5e7edfed9cf3fac5dc28ec73c6b",
      "line": 119,
      "relation": "increases",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Haptoglobin binds to hemoglobin dimers and forms a high-molecular weight haptoglobin-hemoglobin complex, which is cleared from the circulation after binding to the CD163 receptor on hepatic and splenic macrophages (12).",
      "key": "d5cf18ae95af7d6430af71d9ae1888fd",
      "line": 100,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 14,
      "target": 6
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "By binding cell-free hemoglobin, haptoglobin prevents glomerular filtration of cell-free hemoglobin and subsequent kidney injury (2,7).",
      "key": "023cc0920aeb554b5619e46d0c5495dd",
      "line": 105,
      "relation": "decreases",
      "source": 16,
      "target": 24
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Schaer and colleagues 107 showed that administration of exogenous haptoglobin prevents extravasation of cell free hemoglobin and vasoconstriction in rats (18).",
      "key": "161181b0b5930032301816b7cf1fa84e",
      "line": 111,
      "relation": "decreases",
      "source": 16,
      "target": 8
    },
    {
      "key": "ad7ddd96b67afc293860f6bef2e60696",
      "relation": "partOf",
      "source": 16,
      "target": 12
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Furthermore, haptoglobin retained cell-free 338 hemoglobin in plasma and prevented hemoglobinuria.",
      "key": "f8297c5d1666cdc86c8c221563b8a9c6",
      "line": 205,
      "relation": "decreases",
      "source": 16,
      "target": 25
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "In mice fed a HFD or in 339 diabetic mice fed a normal diet, haptoglobin mixed with murine tetrameric 340 hemoglobin in a 1:1 weight ratio also retained cell-free hemoglobin in plasma and 341 prevented hemoglobinuria but did not reduce hemoglobin-induced hypertension.",
      "key": "14fe141f461d0f2f5c9ff08b9c06c86d",
      "line": 213,
      "relation": "decreases",
      "source": 16,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "In the 358 current study, we demonstrated that administration of human haptoglobin retained 359 cell-free hemoglobin in plasma, prevented hemoglobinuria, and reduced the 360 hemoglobin-induced hypertension in healthy awake mice (see Figure 1A).",
      "key": "4e90a777335d6e88dbcac655e601c6c0",
      "line": 239,
      "relation": "decreases",
      "source": 16,
      "target": 25
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Recent data suggest that haptoglobin prevents hemoglobin-induced hypertension by 355 a similar mechanism (18).",
      "key": "39b313f53155df81968f2ad03ae862c3",
      "line": 232,
      "relation": "decreases",
      "source": 16,
      "target": 27
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "In the 358 current study, we demonstrated that administration of human haptoglobin retained 359 cell-free hemoglobin in plasma, prevented hemoglobinuria, and reduced the 360 hemoglobin-induced hypertension in healthy awake mice (see Figure 1A).",
      "key": "610b52b47768cf096945440424b4de5a",
      "line": 240,
      "relation": "decreases",
      "source": 16,
      "target": 27
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Likewise, 395 infusion of haptoglobin or hemopexin in HbS mice inhibited hemoglobin-dependent 396 vaso-occlusion (3).",
      "key": "6bfde772d0432bcc216a5ad6b5668d2d",
      "line": 262,
      "relation": "decreases",
      "source": 16,
      "target": 23
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Mice with diabetes mellitus or hyperlipidemia have evidence of endothelial dysfunction, which is associated with reduced nitric oxide synthase (NOS) 3 activity (15, 16).",
      "key": "fe9dbbbfdbcc4dd835766eef0d1d5447",
      "line": 125,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 26,
      "target": 5
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Endothelial dysfunction, a condition associated with reduced bioavailability of 282 vascular NO, occurs in humans and mice with hyperlipidemia (16).",
      "key": "1b98c7af2342c45bfa9e3a72b884011e",
      "line": 181,
      "relation": "increases",
      "source": 26,
      "target": 22
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Co-administration of haptoglobin attenuated the hemoglobin-induced increase in SBP during the 40 minutes after co-injection by an average of 13±3 mmHg (Figure 1A).",
      "key": "fed742455222b5d6929087c00f6f4904",
      "line": 141,
      "relation": "decreases",
      "source": 12,
      "target": 9
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "These results 230 suggest that co-injection of haptoglobin but not hemopexin with cell-free hemoglobin 231 can prevent hemoglobin-induced hypertension in awake, healthy mice.",
      "key": "83adcfddcb9f419019607f08ca846d6a",
      "line": 153,
      "relation": "decreases",
      "source": 12,
      "target": 27
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Haptoglobin binds to cell-free hemoglobin and thereby prevents glomerular filtration 237 (6).",
      "key": "9b0c4beb339de9742b60d50fe0713299",
      "line": 158,
      "relation": "decreases",
      "source": 12,
      "target": 10
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Mice that received cell free hemoglobin together with haptoglobin had significantly higher plasma NO 258 consumption than mice that received cell-free hemoglobin alone at 60 minutes after 259 injection.",
      "key": "ea4ef0c540a239dbd8dff7002a07b52c",
      "line": 170,
      "relation": "increases",
      "source": 12,
      "target": 4
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Taken together these results suggest that infusion of cell-free hemoglobin 264 mixed with an equal mass of haptoglobin is sufficient to bind cell-free hemoglobin 265 and prevent renal clearance of extracellular hemoglobin.",
      "key": "dbbe5df937e94a07b09779ecf932db44",
      "line": 176,
      "relation": "decreases",
      "source": 12,
      "target": 25
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "SBP increased 224 on average 20±2 mmHg in mice injected with hemoglobin mixed with hemopexin and 225 therefore was similar to the increase after hemoglobin injection alone.",
      "key": "1fcb4d70ff184b5915b69b13817cca75",
      "line": 147,
      "relation": "increases",
      "source": 13,
      "target": 9
    },
    {
      "key": "2fbb74b78bec9f7a63ef710ecd1564c2",
      "relation": "partOf",
      "source": 17,
      "target": 13
    },
    {
      "annotations": {
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "These results show that, in contrast to haptoglobin, hemopexin 247 was unable to prevent free hemoglobin-induced hemoglobinuria.",
      "key": "9f21b29d5855a018bf36f81ef39b68f2",
      "line": 163,
      "relation": "increases",
      "source": 17,
      "target": 25
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "In mouse models associated with 392 chronic hemolysis and heme overload, such as in mice with a sickle hemoglobin 393 (HbS) gene knock-in or mouse models of β-thalassemia, repeated treatment with 394 hemopexin was shown to reduce chronically elevated blood pressure (21).",
      "key": "cb24f76739b0e4db252726aac58d3750",
      "line": 256,
      "relation": "decreases",
      "source": 17,
      "target": 9
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "The mechanism postulated for the beneficial effects 398 of hemopexin in mouse models of chronic hemolysis involves inhibition of heme399 dependent activation of TLR4 signaling and a combination of reduced endothelial 400 formation of reactive oxygen species and restored endothelial NOS-activity.",
      "key": "d3f1c5cb9ab7cf0787efff1ebd834e12",
      "line": 269,
      "relation": "decreases",
      "source": 17,
      "target": 20
    },
    {
      "key": "32137c422157c99c21c08b1e7a2f0465",
      "relation": "hasReactant",
      "source": 29,
      "target": 0
    },
    {
      "key": "6670525c42890c9eabe9e5a9bec920b0",
      "relation": "hasProduct",
      "source": 29,
      "target": 2
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).",
      "key": "28a2b771205dd629058a124eba638962",
      "line": 247,
      "relation": "increases",
      "source": 1,
      "target": 7
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).",
      "key": "6043ec68f7f8cbd5c081264b20af93eb",
      "line": 248,
      "relation": "increases",
      "source": 1,
      "target": 28
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "Increased plasma concentrations of cell-free heme, the breakdown product of 390 hemoglobin, promote activation and inflammation of endothelial cells and enhance 391 oxidative stress and vascular permeability (22).",
      "key": "54bf770592b3667116431a4ea249dd96",
      "line": 249,
      "relation": "increases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "TLR4 401 activation by free heme would induce mobilization of P-selectin and von Willebrand 402 factor to the endothelial surface that triggers VCAM-1, ICAM-1, and E-selectin403 dependent hemostasis and vasoocclusion (3, 4).",
      "key": "a96ee77f53b6e88b3493b7d93292e104",
      "line": 276,
      "relation": "increases",
      "source": 20,
      "target": 21
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "TLR4 401 activation by free heme would induce mobilization of P-selectin and von Willebrand 402 factor to the endothelial surface that triggers VCAM-1, ICAM-1, and E-selectin403 dependent hemostasis and vasoocclusion (3, 4).",
      "key": "fc781806f961db207aa0cbd630a0377b",
      "line": 277,
      "relation": "increases",
      "source": 20,
      "target": 18
    },
    {
      "annotations": {
        "Cell": {
          "endothelial cell": true
        },
        "MeSHAnatomy": {
          "Arteries": true
        },
        "MeSHDisease": {
          "Diabetes Mellitus": true
        },
        "TextLocation": {
          "Introduction": true
        }
      },
      "citation": {
        "authors": [
          "Bloch DB",
          "Buys ES",
          "Graw JA",
          "Rezoagli E",
          "Warren HS",
          "Yu B",
          "Zapol WM"
        ],
        "date": "2017-06-01",
        "db": "PubMed",
        "db_id": "28314763",
        "db_name": "American journal of physiology. Heart and circulatory physiology",
        "first": "Graw JA",
        "last": "Zapol WM",
        "pages": "H1120-H1127",
        "volume": "312"
      },
      "evidence": "TLR4 401 activation by free heme would induce mobilization of P-selectin and von Willebrand 402 factor to the endothelial surface that triggers VCAM-1, ICAM-1, and E-selectin403 dependent hemostasis and vasoocclusion (3, 4).",
      "key": "316114bd7655b6810c74a0a82a9f9c1f",
      "line": 278,
      "relation": "increases",
      "source": 20,
      "target": 19
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "concept": {
        "name": "nitric oxide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
    },
    {
      "bel": "a(CHEBI:heme)",
      "concept": {
        "name": "heme",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "784587e400a7972b75c28341c34a7ccc"
    },
    {
      "bel": "a(CHEBI:nitrate)",
      "concept": {
        "name": "nitrate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "fc1c47dd734d1baf65b485e666d19aa4"
    },
    {
      "bel": "a(HM:\"Nitric oxide scavenging\")",
      "concept": {
        "name": "Nitric oxide scavenging",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "9ddf41f183874a735a245ef9dbcfda58"
    },
    {
      "bel": "a(HM:\"nitric oxide consumption\")",
      "concept": {
        "name": "nitric oxide consumption",
        "namespace": "HM"
      },
      "function": "Abundance",
      "id": "afda0664868800924e299d8594e6a80f"
    },
    {
      "bel": "a(MESH:\"Nitric Oxide Synthase\")",
      "concept": {
        "name": "Nitric Oxide Synthase",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "bd94ac7af9f73e423465705ae6af4797"
    },
    {
      "bel": "a(MESH:\"haptoglobin-hemoglobin complex\")",
      "concept": {
        "name": "haptoglobin-hemoglobin complex",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9ef10404e8021d43bebc646c11e50068"
    },
    {
      "bel": "bp(GO:\"endothelial cell activation\")",
      "concept": {
        "name": "endothelial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f96b4da95b8d4968c158a5aade426691"
    },
    {
      "bel": "bp(GO:vasoconstriction)",
      "concept": {
        "name": "vasoconstriction",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "407b9c02f282c6a2ac0ba14924d4ebd7"
    },
    {
      "bel": "bp(MESH:\"Blood Pressure\")",
      "concept": {
        "name": "Blood Pressure",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "fe4965bd3798a9aa6b28451e5d343b76"
    },
    {
      "bel": "bp(MESH:\"Glomerular Filtration Rate\")",
      "concept": {
        "name": "Glomerular Filtration Rate",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "3b10dfe91bb879f348a78a1b7ee9b98d"
    },
    {
      "bel": "bp(MESH:\"Oxidative Stress\")",
      "concept": {
        "name": "Oxidative Stress",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9174b724412892a12c4da7cab55f893c"
    },
    {
      "bel": "complex(p(HGNC:HBB), p(MGI:Hp))",
      "function": "Complex",
      "id": "52539ed2782de3c64bb999646f6f94b9",
      "members": [
        {
          "bel": "p(HGNC:HBB)",
          "concept": {
            "name": "HBB",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "15ee95d6d880d241c742461c7f432f15"
        },
        {
          "bel": "p(MGI:Hp)",
          "concept": {
            "name": "Hp",
            "namespace": "MGI"
          },
          "function": "Protein",
          "id": "13f5a151541d81593768f8cddf6333ad"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HBB), p(MGI:Hpx))",
      "function": "Complex",
      "id": "3296d469043a9a4c6398dfc5fe6cb3c5",
      "members": [
        {
          "bel": "p(HGNC:HBB)",
          "concept": {
            "name": "HBB",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "15ee95d6d880d241c742461c7f432f15"
        },
        {
          "bel": "p(MGI:Hpx)",
          "concept": {
            "name": "Hpx",
            "namespace": "MGI"
          },
          "function": "Protein",
          "id": "31e4aedd4a04f422b4b3ddab695d1968"
        }
      ]
    },
    {
      "bel": "p(HGNC:CD163)",
      "concept": {
        "name": "CD163",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7a4ce4552870e57e513aea99fdc5e600"
    },
    {
      "bel": "p(HGNC:HBB)",
      "concept": {
        "name": "HBB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "15ee95d6d880d241c742461c7f432f15"
    },
    {
      "bel": "p(MGI:Hp)",
      "concept": {
        "name": "Hp",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "13f5a151541d81593768f8cddf6333ad"
    },
    {
      "bel": "p(MGI:Hpx)",
      "concept": {
        "name": "Hpx",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "31e4aedd4a04f422b4b3ddab695d1968"
    },
    {
      "bel": "p(MGI:Icam1)",
      "concept": {
        "name": "Icam1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "e4f8f8b9ff408365818d0a83b7a008c6"
    },
    {
      "bel": "p(MGI:Sele)",
      "concept": {
        "name": "Sele",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "467f23ae62a3978a80fc9678b4583b39"
    },
    {
      "bel": "p(MGI:Tlr4)",
      "concept": {
        "name": "Tlr4",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "cdbb893bb48412074a7b602932947efa"
    },
    {
      "bel": "p(MGI:Vcam1)",
      "concept": {
        "name": "Vcam1",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "77770e833b487db3f60e4d7c5c5dfe76"
    },
    {
      "bel": "path(HM:\"Endothelial dysfunction\")",
      "concept": {
        "name": "Endothelial dysfunction",
        "namespace": "HM"
      },
      "function": "Pathology",
      "id": "336bca6d17802a49e311f8095bc60307"
    },
    {
      "bel": "path(HM:\"vaso-occlusive crisis\")",
      "concept": {
        "name": "vaso-occlusive crisis",
        "namespace": "HM"
      },
      "function": "Pathology",
      "id": "2b00d9348c1c219626e7059edcd4f283"
    },
    {
      "bel": "path(MESH:\"Acute Kidney Injury\")",
      "concept": {
        "name": "Acute Kidney Injury",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "c79b5c3cb64cd6a386a6983c7f4dbbdb"
    },
    {
      "bel": "path(MESH:Hemoglobinuria)",
      "concept": {
        "name": "Hemoglobinuria",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "39fa7a941922a649b5dae0f08d2b503b"
    },
    {
      "bel": "path(MESH:Hyperlipidemias)",
      "concept": {
        "name": "Hyperlipidemias",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "3399e2af99624ec0d70b1be829440eed"
    },
    {
      "bel": "path(MESH:Hypertension)",
      "concept": {
        "name": "Hypertension",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "dfc5303e42570a3507bbb51f1a445664"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "rxn(reactants(a(CHEBI:\"nitric oxide\")), products(a(CHEBI:nitrate)))",
      "function": "Reaction",
      "id": "bffc811386e32e6d4731b67b79baa232",
      "products": [
        {
          "bel": "a(CHEBI:nitrate)",
          "concept": {
            "name": "nitrate",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "fc1c47dd734d1baf65b485e666d19aa4"
        }
      ],
      "reactants": [
        {
          "bel": "a(CHEBI:\"nitric oxide\")",
          "concept": {
            "name": "nitric oxide",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "da5a3d810aacb9c4649ec7df3b5f60d3"
        }
      ]
    }
  ]
}